eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
5/2024
vol. 41
 
Share:
Send email
Share:
Original paper

Association of the expression of Bcl-2 and Ki-67 prognostic markers and apoptotic index with biological behaviour in aggressive and non-aggressive non-melanoma eyelid skin cancer

Zuzana Prídavková
1, 2, 3
,
Lukáš Plank
4
,
Peter Žiak
1, 5
,
Karolína Benca-Kapitánová
1
,
Rastislav Vida
1
,
Vladimír Bartoš
6

  1. UVEA Eye Clinic s. r. o., Martin, Slovakia
  2. Department of Ophthalmology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
  3. Department of Ophthalmology, Central Military Hospital, Ružomberok, Slovakia
  4. Department of Pathological Anatomy, Jessenius Faculty of Medicine and University Hospital in Martin, Comenius University in Bratislava, Slovakia
  5. Eye Clinic, Jessenius Faculty of Medicine, Martin, Slovakia
  6. Martin’s Biopsy Center, Ltd., Martin, Slovakia
Adv Dermatol Allergol 2024; XLI (5): 456-462
DOI: https://doi.org/10.5114/ada.2024.144402
Online publish date: 2024/10/23
Article file
- Association - Prídavková.pdf  [0.18 MB]
Get citation
 
 
1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (suppl 61): 1-6.
2. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003; 327: 794-8.
3. Tilli CM, Van Steensel MA, Krekels GA, et al. Molecular aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol 2005; 152: 1108-24.
4. Quazi SJ, Aslam N, Saleem H et al. Surgical margin of excision in basal cell carcinoma: a systematic review of literature. Cureus 2020; 12: e9211.
5. Furdová A, Horkovičová K, Babál P, et al. Nemelanómové nádory kože mihalníc a vnútorného kútika – bazocelulárny karcinóm [Non-melanotic Tumors of the Eyelids Skin and Inner Corner – Basocellular Carcinoma]. Cesk Slov Oftalmol 2015; 71: 293-301. Czech.
6. Trager MH, Geskin LJ, Samie FH, Liu L. Biomarkers in melanoma and non-melanoma skin cancer prevention and risk stratification. Exp Dermatol 2022; 31: 4-12.
7. Ashkenazi A, Fairbrother WJ, Leverson JD, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov 2017; 16: 273-84.
8. Yerebakan O, Ciftçioglu MA, Akkaya BK, Yilmaz E. Prognostic value of Ki-67, CD31 and epidermal growth factor receptor expression in basal cell carcinoma. J Dermatol 2003; 30: 33-41.
9. Staibano S, Lo Muzio L, Pannone G, et al. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck. Anticancer Res 2001; 21: 3757-64.
10. Bumpous JM, Padhya TA, Barnett SN. Basal cell carcinoma of the head and neck: identification of predictors of recurrence. Ear Nose Throat J 2000; 79: 200-2, 204.
11. Kim DP, Kus KJB, Ruiz E. Basal cell carcinoma review. Hematol Oncol Clin North Am 2019; 33: 13-24.
12. Národný onkologický register | www.noisk.sk [Internet]. www.noisk.sk. [cited 2024 Apr 18]. Available from: http://www.noisk.sk/narodny-onkologicky-register/epidemiologia-nadorovych-ochoreni-na-slovensku
13. Silverman N, Shinder R. What’s new in eyelid tumors. Asia Pac J Ophthalmol (Phila) 2017; 6: 143-52.
14. Ci¹¿yñska M, Kamiñska-Winciorek G, Lange D, et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep 2021; 11: 4337.
15. Watt TC, Inskip PD, Stratton K, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2012; 104: 1240-50.
16. Furdova A, Lukacko P. Periocular basal cell carcinoma predictors for recurrence and infiltration of the orbit. J Craniofac Surg 2017; 28: e84-7.
17. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004; 111: 631-6.
18. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136: 1524-30.
19. Revenga F, Paricio JF, Vázquez MM, Del Villar V. Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma. J Eur Acad Dermatol Venereol 2004; 18: 514-5.
20. Yuan Z, Dewson G, Czabotar PE, Birkinshaw RW. VDAC2 and the BCL-2 family of proteins. Biochem Soc Trans 2021; 49: 2787-95.
21. Ramezani M, Mohamadzaheri E, Khazaei S, et al. Comparison of EMA, CEA, CD10 and Bcl-2 biomarkers by immunohistochemistry in squamous cell carcinoma and basal cell carcinoma of the skin. Asian Pac J Cancer Prev 2016; 17: 1379-83.
22. Sivrikoz O, Kandiloğlu G. The effects of cyclin D1 and Bcl-2 expressıon on aggressive behavior in basal cell and basosquamous carcinoma. Iran J Pathol 2015; 10: 185-91.
23. Puizina-Iviæ N, Sapunar D, Marasoviæ D, Miriæ L. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis. Coll Antropol 2008; 32 Suppl 2: 61-5.
24. Healy E, Angus B, Lawrence CM, Rees JL. Prognostic value of Ki67 antigen expression in basal cell carcinomas. Br J Dermatol 1995; 133: 737-41.
25. Janisson-Dargaud D, Durlach A, Lorenzato M, et al. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma. J Cutan Pathol 2008; 35: 916-21.
26. Newlands C, Currie R, Memon A, et al. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130 (Suppl 2): S125-32.
27. Thomson J, Hogan S, Leonardi-Bee J, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2020; 11: CD003412.
28. Furdová A, Lukačko P, Lederleitner D. HDR 192Ir brachyterapia v liečbe bazocelulárneho karcinómu dolnej mihalnice a vnútorného kútika oka - naše skúsenosti [HDR 192Ir brachytherapy in treatment of basal cell carcinoma of the lower eyelid and inner angle – our experience]. Cesk Slov Oftalmol 2013; 69: 75-9.
29. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010; 375: 673-85.
30. Pricl S, Cortelazzi B, Dal Col V, et al. Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma. Mol Oncol 2015; 9: 389-97.
31. Bakshi A, Chaudhary SC, Rana M, et al. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. Mol Carcinog 2017; 56: 2543-57.
32. Kuonen F, Huskey NE, Shankar G, et al. Loss of primary cilia drives switching from Hedgehog to Ras/MAPK pathway in resistant basal cell carcinoma. J Invest Dermatol 2019; 139: 1439-48.
33. Sekulic A, Migden MR, Lewis K, et al. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol 2015; 72: 1021-6.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.